Orin
VTRNYSE·REIT - Healthcare Facilities

Ventas, Inc. VTR

Market cap $42.3BP/E 157.5× trailingGross margin -2.6%Reports Wed 28 Oct, after the close
$86.94
+0.30 (+0.35%)live 09:30 ET
52-wk $66.93 – $101.60
Watch
Orin's take
0.62conviction · moderate
Refreshed 1 Aug · take v6. A new filing or a print queues the next refresh.

Ventas continues to execute on its senior housing recovery thesis, with FY2025 revenue growing 18.5% to $5.83B, operating income up 21.4% to $827M, and Q2 2026 FFO beating consensus at $0.97 vs. $0.96 alongside raised full-year guidance. However, the stock trades at 19.6x EV/EBITDA — a 33% premium to the peer median of 14.7x — and while the pullback from ~$98 to $93.51 has cooled the technical picture (RSI at 50.1, MACD histogram negative), insiders remain net sellers at $77.8M over 24 months and the smart money score is low at 0.030.

The improving fundamentals are genuine but the valuation premium and persistent insider selling keep the risk/reward balanced rather than compelling at current levels.

What could go wrong

  • Valuation premium unwinds. At 19.6x EV/EBITDA vs. peer median 14.7x, any disappointment in SHOP growth or guidance could trigger a sharp de-rating, especially with the stock still above its 50-day ($89.02) and 200-day ($82.84) MAs.
  • Insider selling persists. Net insider dispositions of $77.8M over 24 months with 110 sell transactions vs. 158 acquisitions suggest limited insider conviction despite the operational turnaround.
  • Interest rate sensitivity. With $13.2B in total debt, rising rates or widening credit spreads could pressure FFO and increase refinancing costs, offsetting SHOP-driven NOI gains.
  • SHOP occupancy reversal. The thesis hinges on continued occupancy gains and rent growth in the senior housing operating portfolio; any slowdown in demographic-driven demand or new supply pressure could stall the recovery.

What would change my mind

EV/EBITDA compression toward peer median. Stock pulls back to the low $80s (approaching the 200-day MA at $82.84), bringing EV/EBITDA closer to the 15-16x range and improving the entry point.bullish
SHOP same-store NOI growth acceleration. Quarterly SHOP same-store NOI growth exceeds 15% YoY with continued occupancy gains, validating the demographic tailwind and justifying the valuation premium.bullish
Guidance cut or SHOP occupancy decline. Management lowers 2026 FFO guidance or reports sequential occupancy declines in the SHOP portfolio, signaling the recovery is stalling.bearish
Insider buying reversal. Insiders shift from net selling to meaningful open-market purchases, signaling confidence in valuation and outlook.bullish

Where this comes from: FMP annual fundamentals · FMP annual fundamentals · Zacks news article, 2026-07-29 · MarketBeat news article, 2026-08-01. Orin's read on VTR; not advice.

Twelve months actual closes to 2026-09-23 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Jpmorgan Chase &$3.9B0.2% of fund
Vanguard Portfolio Management$3.8B0.2% of fund
Vanguard Capital Management$2.8B0.1% of fund
State Street$2.7B0.1% of fund
Fmr$2.3B0.1% of fund
Brasada Capital Management$1.5B0.3% of fund

89 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 270 Form 4 filings, net −$76.4M. Of the 50 on hand, 1 was an open-market purchase and 1 a sale— the rest are grants, option exercises and tax withholding.

Ask Orin about VTR

its filings · its transcripts · its numbers

Orin answers questions about VTR from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days

Where it trades

vs its own 5y · Real Estate
MetricNowOwn medianSector
P/E157.5×56.8×
EV/EBITDA22.3×18.4×
P/S6.54×4.92×
P/B2.9×2.1×

Its P/E sits 60th percentile of its own last 5 years (+0.45σ from its own mean).

What the price assumes

14.1%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $1.3B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

32 firms · 2026-09-23
Consensus target

$100

$88$110 · +15% against today's price

How they rate it
  • 18 buy or overweight
  • 12 hold
  • 2 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 28.4× of 9 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
VTRVentas, Inc.$42B157.5×22.3×-2.6%4.1%2%
AVBAvalonBay Communities, Inc.$26B25.2×18.8×52.7%33.4%9%
CCICrown Castle Inc.$31B28.4×19.5×63.2%25.8%-52%
CSGPCoStar Group, Inc.$11B153.8×27.1×76.5%2.1%1%
DOCHealthpeak Properties, Inc.$14B58.5×12.8×2.5%8.6%3%
EQREquity Residential$24B27.6×14.3×46.0%27.9%8%
EXRExtra Space Storage Inc.$28B29.5×13.3×23.0%28.0%7%
IRMIron Mountain Incorporated$34B82.2×21.4×54.2%5.5%-38%
SBACSBA Communications Corporation$18B18.3×15.7×63.9%34.5%-21%
VICIVICI Properties Inc.$26B9.2×11.9×99.3%67.5%10%

The median is of the 9 peers listed above and nothing else — check it against the column. This company trades 454.0% above it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY14 38.8×FY25 140.7×

What its sector has traded at

Real Estate
FY14 44.0×FY26 52.3×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$199$84.31 · +136%2026-06-10
Levered DCF$112$84.31 · +32%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $86.94
52-week range$67 – $102
Analyst targets$88 – $110
Standard DCF$199 as of 2026-06-10, when it was $84.31
Levered DCF$112 as of 2026-06-10, when it was $84.31
At own 5y-median P/E (140×)$77
At 5y P/E range (-489–399×)$-269 – $220
At sector P/E (57×)$31

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.